Klebsiella Infections (Klebsiella Infection)

01/01/2006 - "This study was undertaken in order to determine whether anti-inflammatory cytokine interleukin-10 is responsible for a previously described protection against Klebsiella infection mediated by antilipopolysaccharide antibodies. "
06/09/2005 - "This study was undertaken in order to determine whether proinflammatory cytokines are involved in a previously described protection against Klebsiella infection mediated by antilipopolysaccharide antibodies. "

01/01/2006 - "IL-10 in antilipopolysaccharide immunity against systemic Klebsiella infections."
09/01/1999 - "Exogenous cytokine modulation or neutralization of interleukin-10 enhance survival in lipopolysaccharide-hyporesponsive C3H/HeJ mice with Klebsiella infection."
01/01/2006 - "This study was undertaken in order to determine whether anti-inflammatory cytokine interleukin-10 is responsible for a previously described protection against Klebsiella infection mediated by antilipopolysaccharide antibodies. "

06/09/2005 - "Proinflammatory cytokines in antilipopolysaccharide immunity against Klebsiella infections."
06/09/2005 - "This study was undertaken in order to determine whether proinflammatory cytokines are involved in a previously described protection against Klebsiella infection mediated by antilipopolysaccharide antibodies. "

08/14/2001 - "The toxoids of KCT-I and PBE were found to be protective against homologous as well as heterologous Klebsiella challenges, while toxoids of KCT-II and KCT-III afforded protection in mice against homologous Klebsiella infections. "

11/01/2012 - "Pathogenic mechanism of klebsiella Infections are associated with virulence factors such as capsule and mucoid phenotype, etc. The present study was designed to determine the virulence factors and antibiogram of klebsiellae, isolated from various clinical specimen in a tertiary care hospital of West Bengal, India. "

07/01/1999 - "In this study, the expression of MHC class I antigens on peripheral blood mononuclear cells (PBMC) from 16 patients with Salmonella, Yersinia, or Klebsiella infection was investigated. "

02/01/1992 - "[Interferon type I in protective body reactions in an experimental Klebsiella infection]."
02/01/1992 - "The study on mice with experimental generalized Klebsiella infection, carried out with the use of microbiologic, immunologic and pathomorphologic methods, revealed that the intraperitoneal injection of type I interferon into the animals prevented their death and led to the rapid elimination of the infective agent from their body, enhanced the phagocytic and metabolic activity of polymorphonuclear lymphocytes of their peritoneal exudate, decreased the manifestation of microcirculatory and dystrophic changes in the parenchyma of their internal organs."

02/17/2004 - "O antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections."
09/01/1997 - "O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections."
09/01/1997 - "Antibodies directed against this epitope may represent a further alternative for O-antigen-targeted immunoprophylaxis of Klebsiella infections. "
09/01/1997 - "These data support further experimental investigations on the protective potential of O-antigen-based vaccines and/or hyperimmune globulins in Klebsiella infection."
02/17/2004 - "Given the limited number of O serogroups, O antigen-specific antibodies may be suited to supplement K antigen-specific hyperimmune globulins for passive immunoprophylaxis of Klebsiella infections."

09/01/1993 - "Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins."
01/01/1989 - "Cephalosporins and aminoglycosides are the best choice for treatment of Klebsiella infections."
12/01/1995 - "Sequential overuse of aminoglycosides and cephalosporins for nosocomial klebsiella infection may select for organisms resistant to both classes of antibiotics."
12/01/1995 - "The incidence of cephalosporin resistance declined during 1991-1992, which was coincident with severe restrictions on the use of third-generation cephalosporins and the preferential use of ciprofloxacin and imipenem for nosocomial klebsiella infections. "

12/01/1983 - "The potential for vaccination against Klebsiella spp. is discussed in light of recent developments concerning the pathogenesis of Klebsiella infections as relates to the identification of protective antigens as possible vaccine candidates."
06/01/1976 - "Significance of circulating capsular antigen in Klebsiella infections."
05/01/1997 - "Thus, since the number of Klebsiella capsular antigens occurring in clinical material is too large to be completely "covered" by a K-antigen-specific hyperimmunoglobulin preparation, O-antigen-specific antibodies may supplement K-antigen-specific immunoprophylaxis and -therapy of clinical Klebsiella infection."

02/01/1992 - "The study on mice with experimental generalized Klebsiella infection, carried out with the use of microbiologic, immunologic and pathomorphologic methods, revealed that the intraperitoneal injection of type I interferon into the animals prevented their death and led to the rapid elimination of the infective agent from their body, enhanced the phagocytic and metabolic activity of polymorphonuclear lymphocytes of their peritoneal exudate, decreased the manifestation of microcirculatory and dystrophic changes in the parenchyma of their internal organs."

12/01/1984 - "Klebsiella infection in a neonatal intensive care unit: role of bacteriological surveillance."
10/01/1984 - "Klebsiella infection in a neonatal intensive care unit."
04/01/1978 - "Gentamicin-resistant Klebsiella infections in a neonatal intensive care unit."

01/01/1977 - "Nosocomial Klebsiella infections in an intensive care nursery."
10/14/1998 - "This was accompanied by a 44.0% reduction in the incidence of ceftazidime-resistant Klebsiella infection and colonization throughout the medical center (P<.01), a 70.9% reduction within all intensive care units (P<.001), and an 87.5% reduction within the surgical intensive care unit (P<.001). "

02/01/1978 - "The frequency of Klebsiella infections in the urological wards dropped significantly after up-grading the treatment room, improving catheter storage and reducing ampicillin use."

04/01/1992 - "Liver transplantation was followed by a significant and rapid increase in serum apoprotein A-I and HDL cholesterol concentrations, which were affected by CMV and Klebsiella infections and acute rejections and immunosuppressive treatments. "